Molecular markers for breast cancer diagnosis, prognosis and targeted therapy. - Wikidata - wikimedia - TriplyDB

Molecular markers for breast cancer diagnosis, prognosis and targeted therapy.

Molecular markers for breast cancer diagnosis, prognosis and targeted therapy.

http://www.wikidata.org/entity/Q38236904

about

Statistical Methods for Establishing Personalized Treatment Rules in Oncology PLA2G7 associates with hormone receptor negativity in clinical breast cancer samples and regulates epithelial-mesenchymal transition in cultured breast cancer cells Current status of the prognostic molecular biomarkers in breast cancer: A systematic review Low expression of PinX1 is associated with malignant behavior in basal-like breast cancer Design and evaluation of a peptide-based immunotoxin for breast cancer therapeutics.TOPK is highly expressed in circulating tumor cells, enabling metastasis of prostate cancer A novel immunotherapy targeting MMP-14 limits hypoxia, immune suppression and metastasis in triple-negative breast cancer models.EpCAM based capture detects and recovers circulating tumor cells from all subtypes of breast cancer except claudin-low.miR-340 and ZEB1 negative feedback loop regulates TGF-β- mediated breast cancer progression Screening of the prognostic targets for breast cancer based co-expression modules analysis.The importance of surgical margins in breast cancer.Comparison of central laboratory assessments of ER, PR, HER2, and Ki67 by IHC/FISH and the corresponding mRNAs (ESR1, PGR, ERBB2, and MKi67) by RT-qPCR on an automated, broadly deployed diagnostic platform

P2860

Q26786366-501E572C-ECDE-48A8-A408-B927B6788E08 Q33593900-063B39F6-874E-483E-80A5-6DBBC74F9D41 Q33598494-5E4DE010-6A45-4712-AED3-E7D1B059CB39 Q33858225-B33437CF-4BBC-46F8-9D7D-4306ADB097D6 Q35244073-1172E158-8246-438C-B8E4-D113F21C0D9D Q35828584-F6AA24B7-4BC5-44A3-8E01-A6D19063916D Q36379157-2AD54C61-0EF2-4973-A9D1-FE18B26DE82E Q36689065-291FF5D3-7903-44B3-BBC9-45F3EE04C4C7 Q37295569-01D6C773-BB2A-41F9-9C86-B99194DB5E65 Q38430904-A114D6B7-F3FC-4D31-B1C7-4F8C59DA3540 Q38591049-C82F870B-33E0-444F-B870-8FD3A6BA653B Q58767252-F7AF2C5F-60D3-4C43-B5D2-385EDAB0C1B2

P2860

Molecular markers for breast cancer diagnosis, prognosis and targeted therapy.

http://www.wikidata.org/entity/Q38236904

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Molecular markers for breast cancer diagnosis, prognosis and targeted therapy.

@en

type

label

Molecular markers for breast cancer diagnosis, prognosis and targeted therapy.

@en

prefLabel

Molecular markers for breast cancer diagnosis, prognosis and targeted therapy.

@en

P1433

Q38236904-EAA6DAC8-400F-427A-A6E0-15164B6F459E

P1476

Q38236904-A11FDDD8-B5F0-4FC8-9239-7D329BEF8562

P2093

Q38236904-4191093D-803B-4D4F-A930-0C5585757759

Q38236904-97D364B1-79B8-481C-8366-AA8764CDC2C6

Q38236904-F4043F4A-89E8-4E84-A685-BB2A3B9A96EB

Q38236904-FA77030A-56C7-4CFB-84F6-EE8A9AFCCECF

P2860

Q38236904-01614D0F-2E2C-40F4-844A-89D0890DB1D8

Q38236904-0202EA97-F94E-4AAE-BCDD-4C23A902E050

Q38236904-02BCE432-E97E-4089-B8BA-085D9291259E

Q38236904-02BED2E2-A10F-4645-A002-29F3FFDE37EB

Q38236904-048E6B05-9971-45FF-8FD9-4498624DDD2A

Q38236904-07CBEC97-6BB4-46A0-BD19-4EB2CC7E96DB

Q38236904-0F446A42-4546-48D2-9E10-C867193B42DA

Q38236904-0FA9440C-093F-49C4-967D-7CA4EED1A797

Q38236904-156D9AA7-22F3-4108-AED2-E54CA702D235

Q38236904-1693EFE2-DBAB-4A92-8037-74621B5B1A22

P304

Q38236904-C6D256AB-0F2F-40E9-B456-E127E2E8F676

P31

Q38236904-2631A051-7C56-4B0A-990B-26D94848596A

P356

Q38236904-286D34F2-59FC-4860-B90C-08EC840B14E5

P433

Q38236904-517117D2-F050-42A8-9E6B-907F7F9B8D78

P478

Q38236904-D28BF084-0D8E-437C-B5B4-C6DFF5ACA885

P577

Q38236904-E343D6C8-ADB5-4034-9678-2E79B86C37F5

P5875

Q38236904-410EB3CA-2F4E-4452-9AA6-B2894B484937

P698

Q38236904-F075C676-BB14-4B54-B9CC-545CA828CB94

P356

P1433

Journal of Surgical Oncology

P1476

Molecular markers for breast cancer diagnosis, prognosis and targeted therapy.

@en

P2093

Debasish Tripathy

http://www.w3.org/2001/XMLSchema#string

Julie E Lang

http://www.w3.org/2001/XMLSchema#string

Julie S Wecsler

http://www.w3.org/2001/XMLSchema#string

Michael F Press

http://www.w3.org/2001/XMLSchema#string

P2860

Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial

Comprehensive molecular portraits of human breast tumours

ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome

Tumor self-seeding by circulating cancer cells

Prospective identification of tumorigenic breast cancer cells

Utility of prognostic genomic tests in breast cancer practice: The IMPAKT 2012 Working Group Consensus Statement

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer.

Estrogen receptor and progesterone receptor as predictive biomarkers of response to endocrine therapy: a prospectively powered pathology study in the Tamoxifen and Exemestane Adjuvant Multinational trial.

Activating HER2 mutations in HER2 gene amplification negative breast cancer

P304

81-90

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JSO.23732

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

111

http://www.w3.org/2001/XMLSchema#string

P577

2014-08-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264499700

http://www.w3.org/2001/XMLSchema#string

P698

25091830

http://www.w3.org/2001/XMLSchema#string